Mepidor 20 mg/ml solution for injection for horses

Ima dovoljenje za promet

Mepivacaine hydrochloride

Prenes kot PDF

Informacije o zdravilu

Ime zdravila:

Mepidor 20 mg/ml solution for injection for horses

Učinkovina:

Na voljo samo v English

Ciljne živalske vrste:

Na voljo samo v Bulgarian Spanish Czech Danish German Estonian Greek English French Italian Latvian Lithuanian Hungarian Dutch Romanian Finnish Swedish Icelandic Norwegian

Pot uporabe:

Epiduralna uporaba
Intraartikularna uporaba

Podatki o zdravilu

Učinkovina / Jakost:

Na voljo samo v English

20.00

milligram(s)

/

1.00

millilitre(s)

Farmacevtska oblika:

Raztopina za injiciranje

Karenca glede na pot uporabe:

Epiduralna uporaba
- Horse
  - Meat and offal
    
    3
    
    day
  - Milk
    
    72
    
    hour
Intraartikularna uporaba
- Horse
  - Meat and offal
    
    3
    
    day
  - Milk
    
    72
    
    hour

Anatomsko-terapevtsko-kemična veterinarska oznaka klasifikacija zdravil, ki se uporabljajo v veterini (ATCvet):

QN01BB03

Pravni status za dobavo/izdajo zdravila:

Zdravilo, ki se izdaja na veterinarski recept

Status dovoljenja za promet z zdravilom:

Valid

Ima dovoljenje za promet v:

Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian

Na voljo v:

Denmark

Opis ovojnine zdravila:

Na voljo samo v English
Na voljo samo v English
Na voljo samo v English

Dodatne informacije

Vrsta dovoljenja:

Na voljo samo v English French Croatian Italian Latvian Finnish Swedish Icelandic Norwegian

Pravna podlaga za izdajo dovoljenja za promet z zdravilom:

Na voljo samo v English Italian Latvian Norwegian

Imetnik dovoljenja za promet z zdravilom:

Vetviva Richter GmbH

Datum dovoljenja za promet z zdravilom:

9/11/2017

Proizvodna mesta, odgovorna za sproščanje serij:

Vetviva Richter GmbH

Pristojni organ:

Danish Medicines Agency

Številka dovoljenja za promet z zdravilom:

59052

Datum spremembe statusa dovoljenja za promet:

9/11/2017

Referenčna država članica:

Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian

Številka postopka:

IE/V/0425/001

Zadevne države članice:

Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish German Estonian English French Italian Dutch Portuguese Slovak Finnish Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Croatian Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Estonian English French Lithuanian Portuguese Swedish Icelandic Norwegian

Za poročila o domnevnih neželenih učinkih zdravil za uporabo v veterinaski medicini obiščite stran: www.adrreports.eu/vet

Dokumenti

Povzetek glavnih značilnosti zdravila

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.

Drugi jeziki (2)

Danish (, INJEKTIONSVÆSKE, OPLØSNING 20 MG-ML)

Objavljeno na dan: 4/05/2022

Prenesi

English (PDF)

Objavljeno na dan: 4/05/2022

Prenesi

Combined File of all Documents

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.

Drugi jeziki (1)

English (PDF)

Objavljeno na dan: 23/11/2025

Prenesi